Page last updated: 2024-08-21

isoxazoles and Diffuse Parenchymal Lung Disease

isoxazoles has been researched along with Diffuse Parenchymal Lung Disease in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's20 (66.67)29.6817
2010's10 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atzeni, F; Benucci, M; Boiardi, L; Sallì, S; Sarzi-Puttini, P1
Arstila, L; Elfving, P; Kaipiainen-Seppänen, O; Kononoff, A; Koskela, H; Rutanen, J1
Chazan, R; Karwat, K; Langfort, R; Maskey-Warzęchowska, M; Szczepankiewicz, B; Szołkowska, M1
Chung, KP; Huang, HN; Keng, LT; Lin, MW1
Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS1
Champion, HC; Girgis, RE; Hassoun, PM; Hummers, LK; Mathai, SC; Wigley, FM; Zaiman, A1
Chikura, B; Dawson, JK; Lane, S1
Inokuma, S; Matsuda, T; Otsuka, T; Saeki, Y; Sagawa, A; Sato, T; Sawada, T; Takemura, T; Takeuchi, T2
Alcorn, N; Madhok, R; Saunders, S1
Chu, CM; Kan, CH; Ng, WL; Tsui, HS; Wong, SP1
Hutchinson, DG; Lee, MA1
Dawson, JK; McLaren, ZL1
Zhang, WX; Zhang, ZQ; Zhao, XW; Zhou, W1
Inokuma, S1
Jacobi, AM; Mohr, M1
McCurry, J1
Scott, DL1
Ito, S; Sumida, T1
Haneda, K; Iwamoto, M; Kamata, Y; Kamimura, T; Masuyama, J; Minota, S; Nara, H; Okazaki, H1
Nakajima, A; Yamanaka, H1
Sugii, S1
Adachi, D; Akiba, H; Akiyama, Y; Hirano, M; Mimura, T; Takeishi, M1
Ernst, P; Hudson, M; Suissa, S1
Kudo, S1
Chida, K; Miyazaki, K; Ogura, T; Sugiyama, Y; Yamaguchi, T1
Hagiyama, H; Harigai, M; Iwai, H; Miyasaka, N; Mizoguchi, F; Ochi, S; Oka, T1
Doi, T; Kato, T; Nikaido, K; Takayama, R1
Choe, JY; Chung, SH; Ju, JH; Kim, HY; Kim, SI; Lee, J; Lee, JH; Lee, SI; Lee, SS; Lee, YH; Park, SH; Yoo, WH; Yoon, CH; Yoon, HJ1
Harada, M; Inokuma, S; Koyama, T; Niiro, H; Ohtani, R; Otsuka, T; Yoshizawa, S1

Reviews

8 review(s) available for isoxazoles and Diffuse Parenchymal Lung Disease

ArticleYear
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
    Expert review of clinical immunology, 2013, Volume: 9, Issue:7

    Topics: Antibodies, Blocking; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methotrexate; Patient Education as Topic; Rituximab; Tumor Necrosis Factor-alpha

2013
Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.
    Medicine, 2016, Volume: 95, Issue:26

    Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Pulmonary Alveoli; Time Factors

2016
Clinical expression of leflunomide-induced pneumonitis.
    Rheumatology (Oxford, England), 2009, Volume: 48, Issue:9

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Pneumonia; Retrospective Studies; Tomography, X-Ray Computed

2009
Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.
    Drug safety, 2009, Volume: 32, Issue:12

    Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Liver; Lung Diseases, Interstitial; Risk Assessment

2009
Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury.
    Expert opinion on drug safety, 2011, Volume: 10, Issue:4

    Topics: Animals; Antirheumatic Agents; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Radiography

2011
[Leflunomide for therapy of rheumatoid arthritis].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Matrix Metalloproteinases; Oxidoreductases; T-Lymphocytes; Tumor Necrosis Factor-alpha

2005
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Reproduction; Sulfasalazine

2005
[Drug induced lung injuries in Japanese population].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Asian People; Bleomycin; Gefitinib; Genetic Predisposition to Disease; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Pulmonary Alveoli; Quinazolines; Racial Groups

2006

Other Studies

22 other study(ies) available for isoxazoles and Diffuse Parenchymal Lung Disease

ArticleYear
Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.
    Scandinavian journal of rheumatology, 2014, Volume: 43, Issue:3

    Topics: Aged; Arthritis, Rheumatoid; Disease Progression; Drug Interactions; Drug Therapy, Combination; Female; Finland; Humans; Incidence; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Prognosis; Risk Assessment; Sampling Studies; Survival Rate

2014
Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis.
    Pneumonologia i alergologia polska, 2015, Volume: 83, Issue:1

    Topics: Adjuvants, Immunologic; Arthritis, Rheumatoid; Fatal Outcome; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Radiography, Thoracic

2015
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2016, 12-18, Volume: 48, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders

2016
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Arthritis and rheumatism, 2009, Volume: 60, Issue:2

    Topics: Bosentan; Cohort Studies; Comorbidity; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Lung Diseases, Interstitial; Male; Maryland; Middle Aged; Piperazines; Prognosis; Proportional Hazards Models; Purines; Receptors, Endothelin; Scleroderma, Diffuse; Scleroderma, Systemic; Sildenafil Citrate; Sulfonamides; Sulfones; Survival Rate; Thiophenes; Vasodilator Agents

2009
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
    Rheumatology (Oxford, England), 2009, Volume: 48, Issue:9

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Weight; Female; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Prevalence; Product Surveillance, Postmarketing; Risk Factors; Smoking

2009
Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
    Rheumatology (Oxford, England), 2009, Volume: 48, Issue:10

    Topics: Aged; Aniline Compounds; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Crotonates; Female; Humans; Hydroxybutyrates; Hypoxia; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Male; Middle Aged; Nitriles; Product Surveillance, Postmarketing; Prognosis; Respiration, Artificial; Risk Factors; Serum Albumin; Toluidines

2009
Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:8

    Topics: Adult; Alveolitis, Extrinsic Allergic; Anion Exchange Resins; Antirheumatic Agents; Arthritis, Rheumatoid; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial

2009
HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:6

    Topics: Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Radiographic Image Enhancement; Respiratory Function Tests; Tomography, X-Ray Computed

2010
Comment on: Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:8

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cause of Death; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Risk Factors

2010
Interstitial lung diseases after leflunomide use in nephropathy: an analysis of reported cases in Chinese literature.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Child; China; Female; Humans; IgA Vasculitis; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Nephrotic Syndrome; Prognosis; Survival Rate; Young Adult

2011
Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.
    Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Dyspnea; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methotrexate; Middle Aged; Peptides, Cyclic; Radiography; Receptors, Interleukin-6; Rheumatoid Factor; Steroids

2011
Japan deaths spark concerns over arthritis drug.
    Lancet (London, England), 2004, Feb-07, Volume: 363, Issue:9407

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cause of Death; Drug Approval; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Treatment Outcome

2004
Interstitial lung disease and disease modifying anti-rheumatic drugs.
    Lancet (London, England), 2004, Apr-10, Volume: 363, Issue:9416

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial

2004
Interstitial lung disease associated with leflunomide.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial

2004
Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:12

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Eruptions; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged

2004
Leflunomide induced acute interstitial pneumonia.
    The Journal of rheumatology, 2005, Volume: 32, Issue:6

    Topics: Adjuvants, Immunologic; Arthritis, Rheumatoid; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Radiography, Thoracic; Treatment Outcome

2005
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:5

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Risk Factors

2006
[Diagnosis of and therapy for diffuse lung diseases (discussion)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6

    Topics: Alveolitis, Extrinsic Allergic; Biomarkers; Bronchiolitis; Gefitinib; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Quinazolines; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed

2006
Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
    Modern rheumatology, 2006, Volume: 16, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methylprednisolone; Pulmonary Alveoli; Tomography, X-Ray Computed

2006
[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant].
    No to hattatsu = Brain and development, 2007, Volume: 39, Issue:1

    Topics: Anticonvulsants; Epilepsy; Female; Humans; Infant; Isoxazoles; Lung Diseases, Interstitial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Spasms, Infantile; Valproic Acid; Zonisamide

2007
Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:6

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Korea; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Risk Factors

2007
Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.
    Modern rheumatology, 2008, Volume: 18, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Administration Schedule; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lymphocyte Count; Middle Aged; Pulmonary Fibrosis

2008